1-7 of 7
Keywords: Immunotherapy
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (2013) 36 (10): 578–581.
Published Online: 17 September 2013
... to in the content or advertisements. S100B Melanoma Immunotherapy Monoclonal antibody Biomarker Melanom Immuntherapie Monoklonaler Antikörper Biomarker S100B Hintergrund: CTLA-4 (cytotoxic T lymphocyte-associated antigen-4) ist ein die Immunantwort regulierendes Protein, das...
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1996) 19 (2): 114–117.
Published Online: 12 May 2009
... models of immunotherapy for human tumors. Several clinical trials employing different target and effector cells for the evaluation of the feasibility, toxicity, and efficacy of Bi-MAb therapy have recently been started. The low toxicity and surprising efficacy of the systemic application of an NK-cell...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1996) 19 (6): 480–488.
Published Online: 12 May 2009
... out to be superior in delaying tumor recurrence. Intravesical immunotherapy, using bacillus Calmette Guérin (BCG), seems to be as effective and maybe superior in high-risk groups in delaying tumor recurrence compared to chemotherapeutic agents. The side effects, however, are a disadvantage. The exact...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1992) 15 (6): 490–496.
Published Online: 29 April 2009
...P. Mallmann; A.M. Eis-Hübinger; D. Krebs Background: Active specific immunotherapy with Newcastle disease virus-modified autologous tumor cells (ASI) is able to induce a tumor-specific T-cell-dependent immune response. It was the aim of the following study to increase the clinical effect of ASI...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1992) 15 (2): 102–110.
Published Online: 28 April 2009
... clinical trials or by combining traditional chemotherapy with different types of immunostimulators, are discussed. Their therapeutic efficacy in the adjuvant setting can only be confirmed if large-scale Phase III trials are performed. Stomach neoplasms Adjuvant chemotherapy Immunotherapy...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1991) 14 (2): 123–136.
Published Online: 28 April 2009
... for both regional chemotherapy and regional immunotherapy. Intraperitoneal chemotherapy has been used, with limited success for about 30 years. This mode of therapy is complex and the modest results are probably largely due to procedure associated problems and the fact that it has been applied mostly...